Skip to main content

Table 1 Socio-demographic characteristics, TB and drug use history, and test results of the participants

From: Enhanced tuberculosis case detection among substitution treatment patients: a randomized controlled trial

Characteristic

Total

Control group

Case management group

Male participants (%, 95% CI)

64.9 (55.8-73.9)

61.8 (48.7-74.9)

67.9 (55.4-80.3)

Mean age in years (SD; range)

26.2 (4.2; 19-48)

26.3 (3.1; 20-33)

26.0 (5.2; 19-48)

Sample younger than 30 years of age (%, 95% CI)

83.9 (77.0-90.8)

82.1 (71.9-92.4)

85.7 (76.4-95.1)

Ethnicity (%, 95% CI)

   

Estonian

9.8 (4.2-15.4)

8.9 (1.3-16.5)

10.7 (2.5-19.0)

Other

90.2 (84.6-96.8)

91.1 (83.5-98.7)

89.3 (81.0-97.5)

Persons with less than 12 years of education (%, 95% CI)

56.3 (46.9-65.6)

51.8 (38.4-65.1)

60.7 (47.7-73.8)

Percentage of employed participants (%, 95% CI)

49.1 (39.7-58.5)

48.2 (34.9-61.6)

50.0 (36.6-63.4)

Percentage of participants who had been in prison at least once in lifetime (%, 95% CI)

61.6 (52.5-70.6)

67.9 (55.4-80.3)

55.4 (42.1-68.6)

Mean age at initiation of IDU (SD; range)

16.8 (3.3; 11-30)

17.3 (3.6; 11-26)

16.2 (3.0; 11-30)

Mean duration of IDU in years (SD; range)

9.4 (3.6; 2-24)

9.0 (3.4; 2-20)

9.8 (3.8; 4-24)

Percentage uninsured by the national health insurance (%, 95% CI)

36.6 (27.5-45.7)

35.7 (22.9-48.5)

37.5 (24.6-50.4)

Percentage of people with TB contacts (%, 95% CI)

24.1 (16.1-32.2)

66.7 (53.4-79.9)

81.1 (70.4-91.9)

Percentage of people who had had TB (%, 95% CI)

0.0

0.0

0.0

Percentage HIV-antibody positive

86.2 (79.7-92.8)

88.7 (80.0-97.4)

83.9 (74.1-93.7)

Percentage IGRA-positive (%, 95% CI)

7.4 (2.4-12.4)

9.4 (1.4-17.5)

5.5 (0.0-11.6)

Percentage Mantoux-positive (≥5 mm) (%, 95% CI)

17.0 (9.9-24.0)

19.6 (9.0-30.3)

14.3 (4.9-23.6)